<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03900221</url>
  </required_header>
  <id_info>
    <org_study_id>69HCL18_0631</org_study_id>
    <secondary_id>2018-A02552-53</secondary_id>
    <nct_id>NCT03900221</nct_id>
  </id_info>
  <brief_title>French Registry for Monitoring Pregnancies for Multiple Sclerosis</brief_title>
  <acronym>RESPONSE</acronym>
  <official_title>French Registry for Monitoring Pregnancies and Children of Women With Multiple Sclerosis Within The Observatoire Français de la Sclérose en Plaque (OFSEP) Cohort</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospices Civils de Lyon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospices Civils de Lyon</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The influence of pregnancy on the course of multiple sclerosis (MS) has long been a
      controversial topic. After the publication of the first large prospective study of pregnancy
      and MS in 1998, counselling of women with MS has radically changed and many patients have
      been able to fulfill their desire of motherhood. However, there are still some challenges for
      the neurologist, who has to face old unanswered questions or new issues, regarding the use of
      disease modifying drugs (DMDs) in this period of life, effects on the short and long term
      outcome of the mother (in terms of relapses and disability) and the child, role of
      breast-feeding and locoregional analgesia.

      To set up a national prospective pregnancy registry for patients with MS, nested within the
      Observatoire Français de la Sclérose en Plaque (OFSEP) cohort, owing to a better knowledge of
      interactions between MS and pregnancy-related issues (pregnancy itself, locoregional
      analgesia, breastfeeding, impact of using or stopping DMDs on women/children…)
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      METHODOLOGY Prospective, observational, multicentric and national epidemiological study,
      within the scope of the OFSEP, including all groups of patients eligible to participate in
      the Observatoire Français de la Sclérose en Plaque (OFSEP) (definite MS, radiologically
      isolated syndromes, clinically isolated syndromes, neuromyelitis optica (NMO) and NMO
      spectrum disorders), with no age limit and an ongoing pregnancy. Women will be followed
      during pregnancy and in the year after and their children until 6 years of age.

      STATISTICAL ANALYSIS To be determined for each specific question. EXPECTED RESULTS
      Interactions between pregnancy and MS course have been well characterized before the
      therapeutic era. Neurologists and patients are lacking information to weigh benefits and
      risks of DMDs used immediately before or during pregnancy, including short and long-term
      risks to the mother and to the child, but also after delivery. This study should help provide
      better answers to those questions as well as to still controversial questions about
      locoregional analgesia and breastfeeding. By following these patients within the Observatoire
      Français de la Sclérose en Plaque (OFSEP) cohort, the investigator will also have access to a
      comprehensive description of MS before pregnancy but also in the long term.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 12, 2019</start_date>
  <completion_date type="Anticipated">August 12, 2030</completion_date>
  <primary_completion_date type="Anticipated">August 12, 2030</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>2 Years</target_duration>
  <primary_outcome>
    <measure>Number of participants with treatment-related adverse events as assessed by CTCAE v4.0 during pregnancy period</measure>
    <time_frame>up to 2 years</time_frame>
    <description>Description of the current neurological practice of French neurologists regarding disease modifying drugs and desire of pregnancy and evaluation of its short term impact on the risk of relapses.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of participants with treatment-related adverse events as assessed by CTCAE v4.0 during post-partum period</measure>
    <time_frame>up to 2 years</time_frame>
    <description>Description of the current neurological practice of French neurologists regarding disease modifying drugs and desire of pregnancy and evaluation of its short term impact on the risk of relapses.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Sclerosis, Multiple</condition>
  <condition>Neuromyelitis Optica Spectrum Disorder</condition>
  <condition>Myelin Oligodendrocyte Glycoprotein (MOG)-Antibody Related Disorders</condition>
  <condition>Pregnancy Abnormal</condition>
  <arm_group>
    <arm_group_label>Pregnant women with multiple sclerosis or related neurological</arm_group_label>
    <description>Children born to women with multiple sclerosis or related neurological syndromes.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>No intervention</intervention_name>
    <description>No intervention</description>
    <arm_group_label>Pregnant women with multiple sclerosis or related neurological</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Pregnant women with multiple sclerosis or related neurological syndromes
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All groups of patients eligible to participate to the Observatoire Français de la
             Sclérose en Plaque (OFSEP), including :

          -  Definite Multiple sclerosis (MS) according to McDonald criteria

          -  Whatever the clinical course (single attack MS, relapsing-remitting MS, secondary
             progressive MS, primary progressive MS)

          -  Radiologically Isolated Syndromes (RIS) (will be validated by the RIS expert group)

          -  Clinically Isolated Syndromes (CIS)

          -  Neuromyelitis optica (NMO) and NMO spectrum disorders (will be validated by the
             &quot;Neuro-optico-myélite aiguë de Devic et des syndromes neurologiques apparentés&quot;
             (NOMADMUS) expert group)

          -  No age limit (patients under the age of 18 might be included, provided informed
             consent is obtained from the parents)

          -  Ongoing pregnancy: there will be no limit in the gestational age at inclusion. Women
             can be included at any time before delivery, but the gestational age at inclusion will
             be recorded and introduced in the analyses whenever pertinent. However, neurologists
             and patients will be encouraged to start the study as soon as pregnancy is diagnosed.

          -  Able to give informed consent

          -  Able to read and/or understand French

        Exclusion Criteria:

          -  None
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sandra VUKUSIC, Prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospices Civils de Lyon</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sandra VUKUSIC, Prof.</last_name>
    <phone>4 72 68 13 13</phone>
    <phone_ext>+33</phone_ext>
    <email>sandra.vukusic@chu-lyon.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Romain MARIGNIER, MD</last_name>
    <phone>4 72 68 13 13</phone>
    <phone_ext>+33</phone_ext>
    <email>romain.marignier@chu-lyon.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Chu D'Amiens</name>
      <address>
        <city>Amiens</city>
        <zip>80054</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Abdullatif AL KHEDR</last_name>
    </contact>
    <investigator>
      <last_name>Abdullatif AL KHEDR</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hopital Jean Minjoz</name>
      <address>
        <city>Besançon</city>
        <zip>25030</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Eric BERGER</last_name>
    </contact>
    <investigator>
      <last_name>Eric BERGER</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hopital Pellegrin</name>
      <address>
        <city>Bordeaux</city>
        <zip>33076</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Bruno BROCHET</last_name>
    </contact>
    <investigator>
      <last_name>Bruno BROCHET</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Neurologique Pierre Wertheimer</name>
      <address>
        <city>Bron</city>
        <zip>69677</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sandra VUKUSIC</last_name>
      <phone>4 72 68 13 13</phone>
      <phone_ext>+33</phone_ext>
      <email>sandra.vukusic@chu-lyon.fr</email>
    </contact>
    <investigator>
      <last_name>Sandra VUKUSIC</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hopital Cote de Nacre</name>
      <address>
        <city>Caen</city>
        <zip>14033</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Gilles DEFER</last_name>
    </contact>
    <investigator>
      <last_name>Gilles DEFER</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hopital Gabriel Montpied</name>
      <address>
        <city>Clermont-Ferrand</city>
        <zip>63003</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Pierre CLAVELOU</last_name>
    </contact>
    <investigator>
      <last_name>Pierre CLAVELOU</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Sud Francilien</name>
      <address>
        <city>Corbeil-Essonnes</city>
        <zip>91100</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ivania PATRY</last_name>
    </contact>
    <investigator>
      <last_name>Ivania PATRY</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hopital Henri Mondor</name>
      <address>
        <city>Créteil</city>
        <zip>94010</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Alain CREANGE</last_name>
    </contact>
    <investigator>
      <last_name>Alain CREANGE</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hopital Du Bocage</name>
      <address>
        <city>Dijon</city>
        <zip>21079</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Thibault MOREAU</last_name>
    </contact>
    <investigator>
      <last_name>Thibault MOREAU</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Chu de Grenoble</name>
      <address>
        <city>Grenoble</city>
        <zip>38043</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Olivier CASEZ</last_name>
    </contact>
    <investigator>
      <last_name>Olivier CASEZ</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier de Versailles Hôpital Andre Mignot</name>
      <address>
        <city>Le Chesnay</city>
        <zip>78157</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Chantal NIEFLE</last_name>
    </contact>
    <investigator>
      <last_name>Chantal NIEFLE</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Chru de Lille</name>
      <address>
        <city>Lille</city>
        <zip>59037</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Patrick VERMERSCH</last_name>
    </contact>
    <investigator>
      <last_name>Patrick VERMERSCH</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hopital Dupuytren</name>
      <address>
        <city>Limoges</city>
        <zip>87042</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Laurent MAGY</last_name>
    </contact>
    <investigator>
      <last_name>Laurent MAGY</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hopital Timone Adultes</name>
      <address>
        <city>Marseille</city>
        <zip>13385</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jean PELLETIER</last_name>
    </contact>
    <investigator>
      <last_name>Jean PELLETIER</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hopital Gui de Chauliac</name>
      <address>
        <city>Montpellier</city>
        <zip>34295</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Pierre LABAUGE</last_name>
    </contact>
    <investigator>
      <last_name>Pierre LABAUGE</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Central</name>
      <address>
        <city>Nancy</city>
        <zip>54035</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Marc DEBOUVERIE</last_name>
    </contact>
    <investigator>
      <last_name>Marc DEBOUVERIE</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hopital Pasteur</name>
      <address>
        <city>Nice</city>
        <zip>06001</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Christine LEBRUN-FRENAY</last_name>
    </contact>
    <investigator>
      <last_name>Christine LEBRUN-FRENAY</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hopital Caremeau</name>
      <address>
        <city>Nîmes</city>
        <zip>30029</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Eric THOUVENOT</last_name>
    </contact>
    <investigator>
      <last_name>Eric THOUVENOT</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Fondation Rotschild</name>
      <address>
        <city>Paris</city>
        <zip>75019</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Olivier GOUT</last_name>
    </contact>
    <investigator>
      <last_name>Olivier GOUT</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hopital Saint Antoine</name>
      <address>
        <city>Paris</city>
        <zip>75570</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Bruno STANKOFF</last_name>
    </contact>
    <investigator>
      <last_name>Bruno STANKOFF</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hopital Pitie Salpetriere</name>
      <address>
        <city>Paris</city>
        <zip>75651</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Catherine LUBETZKI</last_name>
    </contact>
    <investigator>
      <last_name>Catherine LUBETZKI</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Chi Poissy Saint Germain En Laye</name>
      <address>
        <city>Poissy</city>
        <zip>78303</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Olivier HEINZLEF</last_name>
    </contact>
    <investigator>
      <last_name>Olivier HEINZLEF</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Chr La Miletrie</name>
      <address>
        <city>Poitiers</city>
        <zip>86021</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jean-Philippe NEAU</last_name>
    </contact>
    <investigator>
      <last_name>Jean-Philippe NEAU</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hopital Rene Dubos</name>
      <address>
        <city>Pontoise</city>
        <zip>95300</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Corinne DUPEL-POTTIER</last_name>
    </contact>
    <investigator>
      <last_name>Corinne DUPEL-POTTIER</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hopital de La Maison Blanche</name>
      <address>
        <city>Reims</city>
        <zip>51092</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ayman TOURBAH</last_name>
    </contact>
    <investigator>
      <last_name>Ayman TOURBAH</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hopital Pontchaillou</name>
      <address>
        <city>Rennes</city>
        <zip>35033</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Gilles EDAN</last_name>
    </contact>
    <investigator>
      <last_name>Gilles EDAN</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Charles-Nicolle</name>
      <address>
        <city>Rouen</city>
        <zip>76000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Bertrand BOURRE</last_name>
    </contact>
    <investigator>
      <last_name>Bertrand BOURRE</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier de Saint-Denis</name>
      <address>
        <city>Saint-Denis</city>
        <zip>93200</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Thomas DEBROUCKER</last_name>
    </contact>
    <investigator>
      <last_name>Thomas DEBROUCKER</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hopital G. Et R. Laennec</name>
      <address>
        <city>Saint-Herblain</city>
        <zip>44800</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>David LAPLAUD</last_name>
    </contact>
    <investigator>
      <last_name>David LAPLAUD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hopital Nord</name>
      <address>
        <city>Saint-Priest-en-Jarez</city>
        <zip>42277</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jean-Philippe CAMDESSANCHE</last_name>
    </contact>
    <investigator>
      <last_name>Jean-Philippe CAMDESSANCHE</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hopital Hautepierre</name>
      <address>
        <city>Strasbourg</city>
        <zip>67098</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jérôme DE SEZE</last_name>
    </contact>
    <investigator>
      <last_name>Jérôme DE SEZE</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hopital Purpan</name>
      <address>
        <city>Toulouse</city>
        <zip>31059</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>David BRASSAT</last_name>
    </contact>
    <investigator>
      <last_name>David BRASSAT</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Chru de Tours Hopital Bretonneau</name>
      <address>
        <city>Tours</city>
        <zip>37044</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Anne-Marie GUENNOC</last_name>
    </contact>
    <investigator>
      <last_name>Anne-Marie GUENNOC</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hopital P. Zobda-Quitman</name>
      <address>
        <city>Fort-de-France</city>
        <zip>97200</zip>
        <country>Martinique</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Philippe CABRE</last_name>
    </contact>
    <investigator>
      <last_name>Philippe CABRE</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
    <country>Martinique</country>
  </location_countries>
  <link>
    <url>http://www.ofsep.org</url>
    <description>Related Info</description>
  </link>
  <verification_date>September 2019</verification_date>
  <study_first_submitted>March 8, 2019</study_first_submitted>
  <study_first_submitted_qc>April 1, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">April 2, 2019</study_first_posted>
  <last_update_submitted>September 24, 2019</last_update_submitted>
  <last_update_submitted_qc>September 24, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">September 25, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Multiple sclerosis</keyword>
  <keyword>pregnancy</keyword>
  <keyword>disease modifying drugs</keyword>
  <keyword>breastfeeding</keyword>
  <keyword>loco-regional analgesia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Multiple Sclerosis</mesh_term>
    <mesh_term>Neuromyelitis Optica</mesh_term>
    <mesh_term>Disease</mesh_term>
    <mesh_term>Sclerosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

